rs779149681
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_017613.4(DONSON):c.1047-9A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000048 ( 0 hom. )
Consequence
DONSON
NM_017613.4 splice_polypyrimidine_tract, intron
NM_017613.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.6194
1
Clinical Significance
Conservation
PhyloP100: 0.388
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 21-33582064-T-C is Pathogenic according to our data. Variant chr21-33582064-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 431414.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-33582064-T-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DONSON | NM_017613.4 | c.1047-9A>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000303071.10 | NP_060083.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DONSON | ENST00000303071.10 | c.1047-9A>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_017613.4 | ENSP00000307143 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152190Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251390Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135860
GnomAD3 exomes
AF:
AC:
12
AN:
251390
Hom.:
AF XY:
AC XY:
5
AN XY:
135860
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461636Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727144
GnomAD4 exome
AF:
AC:
70
AN:
1461636
Hom.:
Cov.:
31
AF XY:
AC XY:
31
AN XY:
727144
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74360
GnomAD4 genome
AF:
AC:
6
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microcephaly, short stature, and limb abnormalities Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 14, 2022 | Variant summary: DONSON c.1047-9A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, multiple publications report the variant to have an impact on splicing, specifically a reduction in DONSON transcript levels compared to normal controls as well as significantly increased retention of intron 6 (Reynolds_2017, Evrony_2017). The variant allele was found at a frequency of 4.8e-05 in 251390 control chromosomes. c.1047-9A>G has been reported in the literature in multiple individuals affected with Microcephaly, Short Stature, And Limb Abnormalities including several members of the same family in the homozygous state (Reynolds_2017, Evrony_2017). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 20, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 05, 2017 | - - |
Microcephaly-micromelia syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 05, 2017 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 12, 2022 | This sequence change falls in intron 6 of the DONSON gene. It does not directly change the encoded amino acid sequence of the DONSON protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs779149681, gnomAD 0.01%). For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant results in retention of intron 6 and introduces a premature termination codon (PMID: 28630177). The resulting mRNA is expected to undergo nonsense-mediated decay. Studies have shown that this variant alters DONSON gene expression (PMID: 28191891). ClinVar contains an entry for this variant (Variation ID: 431414). This variant has been observed in individuals with DONSON-related conditions (PMID: 28191891, 28630177). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2022 | Published functional studies demonstrate a damaging effect (Evrony et al., 2017; Reynolds et al., 2017); This variant is associated with the following publications: (PMID: 34426522, 29760432, 28191891, 31191207, 32552793, 28630177, 34645488) - |
DONSON-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 14, 2024 | The DONSON c.1047-9A>G variant is predicted to interfere with splicing. This variant has been reported in the compound heterozygous and homozygous states in patients with microcephalic dwarfism or microcephaly micromelia syndrome, and segregates with the disease in affected family members (Reynolds et al. 2017. PubMed ID: 28191891; Evrony et al. 2017. PubMed ID: 28630177; Family 15DG2154 in Table S1, Maddirevula. 2020. PubMed ID: 32552793; Shamseldin et al. 2021. PubMed ID: 34645488). This variant is predicted to alter splicing based on available splicing prediction programs (Alamut Visual v2.11). In addition, RNA studies suggest that this variant causes intron 6 retention (Evrony et al. 2017. PubMed ID: 28630177). This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -9
Find out detailed SpliceAI scores and Pangolin per-transcript scores at